Brain SPECT in the diagnosis of Alzheimer's disease;SPECT mozku v diagnostice Alzheimerovy nemoci

Psychiatrie

Volumn 12, Issue SUPPL. 3, 2008, Pages 8-11

  Bartoš, Aleš ^a,b,c,d   Píchová, Renata ^d   Trojanová, Helena ^d   Lang, Otto ^d   Řípová, Daniela ^a,b,c  

^a AD Centrum   (Czech Republic)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^c FCentrum Neuropsychiatrických Studií   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

99mTc HMPAO brain SPECT; Alzheimer's disease; Cognitive disorders; Dementia; Mild cognitive impairment; Single photon emission computed tomography

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN PERFUSION; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; NEUROIMAGING; OUTCOME ASSESSMENT; PATIENT CODING; RIGHT HANDEDNESS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 55249116053     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Bartoš A, Rusina R, Lang O, Píchova R, Tošnerova T. Demence v obraze SPECT vyšetření mozku. Praktický lékař 2000; 11: 610-613.
2. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006;368:387-403.
3. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734-746.
4. Hang C, Wahlund LO, Svensson L, Winblad B, Julin P. Cingulate corcex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2002; 12;2:9. http://www.biomedcentral.com/1471-2377/2/9
5. Jagust WJ, Johnson KA, Holman BL. SPECT perfusion imaging in the diagnosis of dementia. J Neuroimaging 1995;5 Suppl 1:S45-52.
6. Langa KM, Foster NL, Larson EB. Mixed dementia emerging concepts and therapeutic implications. JAMA 2004;292:2901-2908.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
8. Newberg AB, Alavi A. Functional neuroimaging in the differential diagnosis of dementia. In Fazekas F, Schmidt R, Alavi A (eds.): Neuroimaging of Normal Aging and Uncommon causes of Dementia ICG Publications 1998, Dordrecht, s. 201-223.
9. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
10. Ryding E. SPECT measurements of brain function in dementia; a review. Acta Neurol Scand Suppl 1996;168:54-58.
11. Small GW. Differential diagnosis and early detection of dementia. Am J Geriatr Psychiatry 1998;6:26-33.
12. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-817.
13. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia? J Neurol Neurosurg Psychiatry 1998;64:306-313.
14. Tien RD, Felsberg GJ, Ferris NJ, Osumi AK. The dementias: correlation of clinical features, pathophysiology, and neuroradiology. AJR Am J Roentgenol 1993;161:245-255.